Healthcare -
Medical - Devices - NYSE - US
$ 123.903
0.571 %
$ 4.17 B
Market Cap
36.44
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Integer Holdings Corporation
| Revenue | 1.72 B |
| Cost Of Revenue | 1.26 B |
| Gross Profit | 459 M |
| Operating Expenses | 251 M |
| Operating Income | 208 M |
| Other Expenses | 88.3 M |
| Net Income | 120 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Jan-2016 | Jan-2015 | Jan-2014 | Dec-2012 | Dec-2011 | Dec-2010 | Jan-2010 | Jan-2009 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | Jan-2004 | Jan-2003 | Dec-2001 | Dec-2000 | Dec-1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||||||||||||||||
| Revenue | 1 716.6 | 1 596.7 | 1 376.1 | 1 221.1 | 1 073.4 | 1 258.1 | 1 215.0 | 1 461.9 | 1 386.8 | 800.4 | 687.8 | 663.9 | 646.2 | 568.8 | 533.4 | 521.8 | 546.6 | 318.7 | 271.1 | 241.1 | 200.1 | 216.4 | 167.3 | 135.6 | 97.8 | 79.2 |
| GROSS PROFIT | ||||||||||||||||||||||||||
| Cost Of Revenue | 1 257.6 | 1 178.4 | 1 017.1 | 884.1 | 787.7 | 903.1 | 852.3 | 1 068.4 | 1 008.5 | 565.3 | 456.4 | 444.6 | 444.5 | 388.5 | 359.8 | 355.4 | 390.9 | 202.7 | 168.7 | 151.5 | 119.4 | 126.5 | 96.4 | 74.7 | 49.0 | 41.1 |
| Gross Profit | 459.0 | 418.3 | 359.0 | 337.0 | 285.7 | 355.0 | 362.7 | 393.6 | 378.3 | 235.1 | 231.4 | 219.3 | 201.6 | 180.4 | 173.6 | 166.4 | 155.8 | 116.0 | 102.4 | 89.6 | 80.7 | 89.8 | 70.9 | 60.9 | 48.8 | 38.2 |
| OPERATING INCOME | ||||||||||||||||||||||||||
| Operating Expenses | 250.8 | 251.0 | 221.5 | 201.3 | 165.1 | 197.4 | 207.1 | 254.1 | 270.0 | 222.0 | 155.7 | 158.0 | 175.8 | 118.7 | 114.1 | 149.4 | 118.7 | 79.9 | 69.1 | 72.7 | 53.8 | 51.6 | 44.2 | 38.5 | 34.4 | 25.7 |
| Selling, General and Administrative Expenses | 185.2 | 175.6 | 160.6 | 141.4 | 109.0 | 138.7 | 142.4 | 161.6 | 153.3 | 102.5 | 90.6 | 88.1 | 81.0 | 72.5 | 64.5 | 70.3 | 72.6 | 50.0 | 38.8 | 50.1 | 31.3 | 31.4 | 24.4 | 18.2 | 11.5 | 9.9 |
| Research and Development Expenses | 53.4 | 63.8 | 60.9 | 52.0 | 48.5 | 46.5 | 48.6 | 55.2 | 55.0 | 53.0 | 49.8 | 54.1 | 52.5 | 45.5 | 45.0 | 33.6 | 31.4 | 29.9 | 24.2 | 18.7 | 18.5 | 17.0 | 14.4 | 12.6 | 9.9 | 9.3 |
| Operating Income | 208.2 | 167.3 | 121.3 | 135.7 | 120.6 | 157.6 | 155.6 | 139.4 | 108.3 | 13.1 | 75.7 | 61.3 | 25.8 | 61.7 | 69.0 | 1.0 | 34.9 | 20.0 | 22.4 | 16.9 | 26.9 | 38.2 | 26.7 | 22.4 | 14.4 | 12.4 |
| PRE-TAX INCOME | ||||||||||||||||||||||||||
| Interest Income Expense | 56.4 | 53.4 | 38.6 | 31.6 | 38.2 | 52.5 | 99.3 | 106.5 | 111.3 | 33.5 | 4.3 | 11.3 | 18.1 | 16.9 | 18.5 | 20.1 | 13.2 | 7.3 | 0 | 0 | 0 | 0 | 0 | 3.6 | 0 | 0 |
| Total Other Income | (60.7) | (60.0) | (45.4) | (34.6) | (34.4) | (52.4) | (94.4) | (76.4) | (91.7) | (28.8) | 0.9 | (12.5) | (19.1) | (13.3) | (19.7) | (19.2) | (7.6) | 8.7 | (15.9) | (1.4) | (3.2) | (4.9) | (5.7) | (3.9) | (12.8) | (14.8) |
| Pre-Tax Income | 147.6 | 107.3 | 76.0 | 101.1 | 86.2 | 105.2 | 61.1 | 21.8 | 1.2 | (15.7) | 76.6 | 48.8 | 6.7 | 48.4 | 49.3 | (18.2) | 27.3 | 28.7 | 23.5 | 15.5 | 23.7 | 33.3 | 21.0 | 18.5 | 1.6 | (2.3) |
| NET INCOME | ||||||||||||||||||||||||||
| Tax Provision | 26.5 | 16.6 | 10.6 | 8.0 | 8.9 | 14.0 | 14.1 | (44.9) | (4.8) | (8.1) | 21.1 | 12.6 | 11.5 | 15.3 | 16.2 | (9.2) | 8.7 | 13.6 | 7.4 | 5.4 | 7.5 | 10.0 | 6.6 | 6.9 | 0.6 | (0.6) |
| Net Income | 119.9 | 90.7 | 66.4 | 96.8 | 77.3 | 96.3 | 168.0 | 66.7 | 6.0 | (7.6) | 55.5 | 36.3 | (4.8) | 33.1 | 33.1 | (9.0) | 18.6 | 15.1 | 16.1 | 10.1 | 16.3 | 23.3 | 14.4 | 8.6 | (0.5) | (2.3) |
| EPS | 3.57 | 2.72 | 1.97 | 2.82 | 2.35 | 2.8 | 5.23 | 2.12 | 0.19 | 0.29 | 2.23 | 1.51 | 0.2 | 1.42 | 1.44 | 0.39 | 0.82 | 0.68 | 0.74 | 0.47 | 0.67 | 1.1 | 0.69 | 0.44 | 0.0387 | 0.18 |